TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Why Teva Pharmaceuticals Shares Are Losing Steam
Play
INVESTING

Teva's Fourth-Quarter Adjusted Earnings Top Forecasts

  • By Dan Weil
  • Feb 10, 2021 8:41 AM EST
PRESS RELEASES

Teva To Present At The J.P. Morgan 2021 Global High Yield And Leveraged Finance Conference

  • By Business Wire
  • Mar 1, 2021 4:00 PM EST
PRESS RELEASES

New Study Published In Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine Treatments

  • By Business Wire
  • Feb 26, 2021 8:00 AM EST
Why Teva Pharmaceuticals Shares Are Losing Steam
INVESTING

Teva's Fourth-Quarter Adjusted Earnings Top Forecasts

  • By Dan Weil
  • Feb 10, 2021 8:41 AM EST
PRESS RELEASES

Teva To Host Conference Call To Discuss Fourth Quarter 2020 Financial Results And 2021 Financial Guidance At 8 A.m. ET On February 10, 2021

  • By Business Wire
  • Jan 8, 2021 3:01 PM EST
PRESS RELEASES

Teva To Present At The 39th Annual J.P. Morgan Healthcare Conference

  • By Business Wire
  • Jan 7, 2021 4:00 PM EST
PRESS RELEASES

Teva And MedinCell Announce Positive Results For Registration Trial Of Investigational Extended-Release Subcutaneous Injectable Risperidone For Patients With Schizophrenia

  • By Business Wire
  • Jan 7, 2021 8:00 AM EST
PRESS RELEASES

DEADLINE TODAY: The Schall Law Firm Announces It Is Investigating Claims Against Teva Pharmaceuticals Industries Limited And Encourages Investors With Losses Of $100,000 To Contact The Firm

  • By Business Wire
  • Nov 23, 2020 8:52 AM EST
Teva Pharmaceuticals Is Probably the Weakest of the Group, Jim Cramer Says
INVESTING

Teva 3rd-Quarter Adjusted Profit Meets Estimate; Revenue Lags

  • By Tony Owusu
  • Nov 5, 2020 9:23 AM EST
PRESS RELEASES

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Teva Pharmaceuticals Industries Limited Of Class Action Lawsuit And Upcoming Deadline - TEVA

  • By PR Newswire
  • Oct 31, 2020 11:27 PM EDT
PRESS RELEASES

ROSEN, A LEADING LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors Of The Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $500K To Contact The Firm - TEVA

  • By PR Newswire
  • Oct 30, 2020 8:40 PM EDT
PRESS RELEASES

Teva, Amazon Web Services And Onica Announce Collaboration To Support Teva's Digihaler® Portfolio

  • By Business Wire
  • Oct 21, 2020 8:00 AM EDT
Magnificent Seven
JIM CRAMER

Magnificent Seven: Cramer's 'Mad Money' Recap (Monday 10/19/20)

  • By Scott Rutt
  • Oct 19, 2020 9:39 PM EDT
PRESS RELEASES

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Teva Pharmaceuticals Industries Limited Of Class Action Lawsuit And Upcoming Deadline - TEVA

  • By PR Newswire
  • Oct 17, 2020 6:40 PM EDT
PRESS RELEASES

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors Of The Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $500K To Contact The Firm - TEVA

  • By PR Newswire
  • Oct 15, 2020 5:45 PM EDT
PRESS RELEASES

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors Of The Important November 23 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - TEVA

  • By Business Wire
  • Oct 5, 2020 5:40 PM EDT
PRESS RELEASES

Teva Canada Announces Availability Of Aermony RespiClick™ (fluticasone Propionate Inhalation Powder), An Innovative New Device For The Treatment Of Bronchial Asthma

  • By Business Wire
  • Oct 5, 2020 8:00 AM EDT
PRESS RELEASES

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces Investigation Of Teva Pharmaceutical Industrial Limited (TEVA) On Behalf Of Investors

  • By Business Wire
  • Oct 1, 2020 12:00 PM EDT
PRESS RELEASES

Teva To Host Conference Call To Discuss Third Quarter 2020 Financial Results At 8 A.m. ET On November 5, 2020

  • By Business Wire
  • Oct 1, 2020 11:06 AM EDT
PRESS RELEASES

Glancy Prongay & Murray LLP, A Leading Securities Fraud Law Firm, Announces Investigation Of Teva Pharmaceutical Industrial Limited (TEVA) On Behalf Of Investors

  • By Business Wire
  • Sep 30, 2020 8:06 PM EDT
PRESS RELEASES

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

  • By Business Wire
  • Sep 28, 2020 8:45 AM EDT
PRESS RELEASES

ROSEN, LEADING INVESTOR COUNSEL, Announces Filing Of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - TEVA

  • By PR Newswire
  • Sep 25, 2020 6:58 PM EDT
PRESS RELEASES

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

  • By Business Wire
  • Sep 24, 2020 5:22 PM EDT
PRESS RELEASES

TEVA EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited - TEVA

  • By Business Wire
  • Sep 24, 2020 3:06 PM EDT
PRESS RELEASES

Pomerantz Law Firm Announces The Filing Of A Class Action Against Teva Pharmaceuticals Industries Limited And Certain Officers - TEVA

  • By PR Newswire
  • Sep 23, 2020 8:20 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.